Rhinitis: all 1,101 studies

Page 10 of 12. Open to participants first (63), then studies with results posted, then the rest; newest registration first within each.

• Single Dose Crossover Study of Patient Preference for Unscented Nasonex® Nasal Spray Versus Scented Flonase® Nasal Spray (Study P04207)CompletedNCT00817050Phase 4
• Desloratadine With Oxybutynin for the Treatment of Seasonal Allergic Rhinitis and Post-Nasal Drip (Study P04258)(COMPLETED)CompletedNCT00816972Phase 2
• Fractional Exhaled Nitric Oxide (FeNO) Result Prediction Factors in Children With Allergic DiseasesCompletedNCT00815984
• Dose-ranging Study to Assess the Efficacy and Safety of Ciclesonide HFA Nasal Aerosol in Adult and Adolescent Patients 12 Years and Older With Seasonal Allergic Rhinitis (SAR) (BY9010/M1-602)CompletedNCT00807053Phase 2
• Investigation of the Efficacy and Safety of Concomitant Administration of Ciclesonide Nasal Spray and Azelastine Nasal Spray in Patients (18 Years or Older) With Perennial Allergic Rhinitis (PAR) Not Adequately Controlled on an Intranasal Corticosteroid or Antihistamine Monotherapy (BY9010/M1-490)CompletedNCT00806754Phase 4
• Study of Nasal Symptom Relief and Side Effects in Hayfever Patients Treated With Aerius (Desloratadine)(P03442)CompletedNCT00805584Phase 4
• Study of the Effectiveness and Safety of Desloratadine (Aerius) Syrup in Children With Hayfever With or Without Asthma (P03472)CompletedNCT00805324Phase 3
• Preference for Clarinex Tablets vs. Zyrtec Tablets in Patients With Allergies (P03180)CompletedNCT00794846Phase 4
• Taste Test Between Desloratadine and Cetirizine Syrup in Children (Study P03826)CompletedNCT00794794Phase 3
• Preference for Clarinex Tablets vs Allegra Tablets in Patients With Seasonal Allergies (P03178)CompletedNCT00794768Phase 4
• Preference for Clarinex Tablets vs. Zyrtec Tablets in Patients With Allergies (P03182)CompletedNCT00794599Phase 4
• Preference for Clarinex Tablets vs. Zyrtec Tablets in Patients With Allergies (P03181)CompletedNCT00794495Phase 4
• Taste Test Between Desloratadine and Cetirizine Syrup in Children (Study P03829)(COMPLETED)CompletedNCT00794378Phase 3
• Preference for Clarinex Tablets vs. Allegra Tablets in Patients With Seasonal Allergies (Study P03179)CompletedNCT00794248Phase 4
• A Pilot Investigation of Ciclesonide When Administered as a Hypotonic Versus an Isotonic Formulation of Ciclesonide Nasal SprayWithdrawnNCT00793858Phase 4
• The Effect of Desloratadine and Levocetirizine on Nasal Obstruction (Study P03609)CompletedNCT00789152Phase 3
• Analysis of Immunological Reactions to Foods in Birch Pollen-Allergic PatientsStatus unknownNCT00787631
• A Study to Compare the Efficacy of QAV680 Against Placebo in Treating Seasonal Allergic Rhinitis in an Environmental Exposure ChamberCompletedNCT00784732Phase 2
• Single Dose Crossover Study of Patient Preference for Unscented Nasonex® Nasal Spray Versus Scented Flonase® Nasal Spray (Study P04208)CompletedNCT00783458Phase 4
• Onset of Effect of Mometasone Nasal Spray in Induced Allergic Rhinitis (Study P03431)CompletedNCT00783237Phase 4
• Efficacy and Safety of Desloratadine vs. Fexofenadine 180 mg. vs. Placebo for Treating Seasonal Allergic Rhinitis (SAR)(Study P04053)(COMPLETED)CompletedNCT00783211Phase 4
• Efficacy and Safety of Desloratadine vs. Fexofenadine 180 mg. vs. Placebo for Treating Seasonal Allergic Rhinitis (SAR) (Study P04054)CompletedNCT00783146Phase 4
• Preference for Clarinex Tablets vs. Allegra Tablets in Patients With Seasonal Allergies (Study P03177)CompletedNCT00783133Phase 4
• Equivalency Study of Two Formulations of Mometasone Furoate Nasal Spray (Study P04419)CompletedNCT00779740Phase 3
• A Study of Mometasone Furoate Nasal Spray in Perennial Allergic Rhinitis (Study P03748)(COMPLETED)CompletedNCT00779545Phase 2
• MK0476 Study in Adult Patients With Perennial Allergic Rhinitis (0476-397)(COMPLETED)CompletedNCT00771160Phase 3
• Tolerability/PoP Study in Allergic Rhinitis After Intranasal Administration of AZD8848CompletedNCT00770003Phase 1
• Observation of Use of Claritin (Loratadine) Tablet, RediTabs, and Dry Syrup in Children (Study P05834)(COMPLETED)CompletedNCT00762983
• Study to Evaluate Diphenhydramine in Children and AdolescentsCompletedNCT00762749Phase 1
• Phenylephrine Pediatric Pharmacokinetic StudyCompletedNCT00762567Phase 1
• Efficacy and Safety Study of BLX-028914 in Subjects With Allergic RhinitisCompletedNCT00758446Phase 2
• Effect of Intranasal Corticosteroids on Systemic Allergen Specific IgECompletedNCT00755066Not applicable
• Probiotics for Birch Pollen AllergyCompletedNCT00746226Phase 1/2
• Fexofenadine Study On Filipino Children for The Relief of Perennial And Intermittent Allergic RhinitisCompletedNCT00741897Phase 4
• Surgical Reduction of the Inferior Turbinates for Nasal ObstructionTerminatedNCT00737906Phase 4
• A Long-term Study of Mometasone Furoate in Patients With Perennial Allergic Rhinitis (Study P04459)CompletedNCT00732368Phase 3
• A Study To Assess The Effect Of SB-705498 In A Capsaicin Challenge ModelCompletedNCT00731250Phase 1
• A Randomized, Double-blind, Placebo-controlled Study on the Effect of CVT-E002 in Patients With Seasonal Allergic RhinitisCompletedNCT00726401Phase 2
• Standardization of Chortoglyphus Arcuatus Allergenic Extract. Determination of Biological Activity in HEP UnitsCompletedNCT00718744Phase 2
• Study of Stool Microbiota in Two Diverse Cohorts of Asian and Its Influence on Allergy DevelopmentCompletedNCT00713089
• Effect of Montelukast on Basophils, In-vitroStatus unknownNCT00710450
• Comparison of Effectiveness and Safety of Sublingual Immunotherapy in Children With Allergic RhinitisCompletedNCT00698594Phase 4
• OC000459 Dose Finding Study in Hay Fever Sufferers.CompletedNCT00697281Phase 2
• Single and Repeat Dose First Time in Human Study for an Intranasal H1/H3 Dual Antagonist in Healthy Male SubjectsCompletedNCT00694993Phase 1
• Tolerability/Safety of Intranasal AZD8848 in Healthy Male Volunteers and Seasonal Allergic Rhinitis Male Patients Out of SeasonCompletedNCT00688779Phase 1
• The Effect of Nasal Carbon Dioxide (CO2) in the Treatment of Seasonal Allergic RhinitisCompletedNCT00688441Phase 2
• Impact of Acupuncture on Vasomotor RhinitisCompletedNCT00682162Phase 3
• To Evaluate Adenosine Monophosphate and Allergen Challenge in Allergic RhinitisCompletedNCT00679250Phase 4
• Phase 2 Study in Adults Sensitized to Short RagweedWithdrawnNCT00670384Phase 2
• To Assess the Safety and Efficacy of Ciclesonide, Applied as a Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (BY9010/M1-401)CompletedNCT00659841Phase 3
• To Assess the Safety and Efficacy of Ciclesonide Applied as a Nasal Spray in the Treatment of Perennial Allergic Rhinitis (BY9010/M1-402)CompletedNCT00659750Phase 3
• Study Using the Environmental Exposure Chamber (EEC) to Assess the Onset of Action of Ciclesonide, Applied as a Nasal Spray in Treatment of Seasonal Allergic Rhinitis (BY9010/M1-406)CompletedNCT00659594Phase 3
• Study Using the Environmental Exposure Unit (EEU) to Assess the Onset of Action of Ciclesonide, Applied as a Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (BY9010/M1-407)CompletedNCT00659503Phase 3
• Investigation of Potential Additive Inhibitory Effects on HPA-Axis of Ciclesonide Nasal Spray When Administered Concomitantly With Orally Inhaled Beclomethasone Dipropionate (HFA-BDP) in Patients With Perennial Allergic Rhinitis (PAR) (BY9010/M1-408)CompletedNCT00659048Phase 3
• To Assess the Safety of Ciclesonide, Applied as a Nasal Spray at Three Dose Levels, in the Treatment of Perennial Allergic Rhinitis in Pediatrics (BY9010/M1-405)CompletedNCT00658918Phase 3
• New Nasal Applicator / New Formulation - User StudyCompletedNCT00641979Phase 2
• Assess the Efficacy and Safety of Rhinocort AquaCompletedNCT00641693Phase 2
• Rhinocort Aqua Versus Placebo and Fluticasone PropionateCompletedNCT00641680Phase 3
• Children, Perennial Allergic Rhinitis (PAR), l-t GrowthCompletedNCT00641212Phase 4
• Efficacy and Safety of Cetirizine Tablets Versus Ketotifen Dry Syrup in Children With Perennial Allergic RhinitisCompletedNCT00639587Phase 3
• The Effect of Nasal Carbon Dioxide (CO2) on Nasal Congestion in Subjects With Perennial Allergic RhinitisCompletedNCT00638755Phase 2
• Fexofenadine HCl 180 mg, Montelukast Sodium 10 mg and Placebo in Suppression of Wheal and Flare Induced by Seasonal AllergenCompletedNCT00638118Phase 4
• A Single-Center, Randomized, Double-Blind, Placebo-Controlled, Two-Way Crossover Study Designed to Evaluate the Efficacy of Fexofenadine HCl 180 mg for Preventing and Controlling Cat Allergy SymptomsCompletedNCT00637884Phase 4
• Single-Center, Double-Blind, Randomized , Parallel Study Comparing Onset of Action, Efficacy & Safety of a Single-Dose of Fexofenadine HCl 180 mg vs Montelukast Na 10 mg & Placebo in Treating Seasonal Allergic Rhinitis Subjects in an Allergen Exposure UnitCompletedNCT00637611Phase 4
• Fexofenadine HCl 180 mg, Desloratadine 5 mg and Placebo in Suppression of Wheal and Flare Induced by HistamineCompletedNCT00637585Phase 4
• Single Center, Randomized, Double-Blind,Crossover Study Comparing Effects Of Single-Dose Fexofenadine HCl 180 mg, Cetirizine 10 mg, and Placebo on Cognitive Performance in Naval Flight PersonnelCompletedNCT00637455Phase 4
• Fexofenadine (Allegra®) in Healthy Adults Who Have Been Identified as Slow Metabolizers for DesloratadineCompletedNCT00636870Phase 4
• CysLT1-r Expression Following Allergen Exposure in Asthma and Allergic RhinitisStatus unknownNCT00631254Not applicable
• Nasal Decongestion and Obstructive Sleep ApneaCompletedNCT00630474Phase 4
• Safety Study of 20,000 EU of Clinical Center Reference Endotoxin in Allergic Adults With and Without Mild AsthmaTerminatedNCT00630461Phase 1
• Efficacy and Safety From a High-dosed Sublingual Grass Pollen PreparationCompletedNCT00623701Phase 3
• Safety and Tolerability of Single and Multiple Doses of VAK694 in Healthy and Atopic SubjectsCompletedNCT00620230Phase 1
• Effects of Diesel Exhaust Followed by Administration of Nasal Spray Flu Vaccine on Individuals With & Without AllergiesCompletedNCT00617110Not applicable
• A Phase II Study Evaluating Intranasal GSK256066 and Fluticasone Propionate in Subjects With Seasonal Allergic Rhinitis (SAR)CompletedNCT00612820Phase 2
• A Phase II Study Evaluating Intranasal GSK256066 and Azelastine Hydrochloride in Subjects With Seasonal Allergic RhinitisCompletedNCT00612118Phase 2
• Acupuncture for Seasonal Allergic RhinitisCompletedNCT00610584Not applicable
• A Study Evaluating Effects of Intranasal JNJ-17166864 on Symptoms of Allergic Rhinitis in AdultsCompletedNCT00604123Phase 2
• Evaluation of Safety of Levocetirizine in Routine Clinical Practice-non- Interventional StudyCompletedNCT00598780
• Oxymetazoline Hydrochloride in Combination With Nasal Glucocorticosteroid for Perennial Allergic and Non-allergic Rhinitis in Subjects With Persistent Nasal CongestionTerminatedNCT00584662Not applicable
• An Exploratory Study of the Effects of a Single Dose of QAX576 (an Interleukin-13 Monoclonal Antibody) on Simulated HayfeverCompletedNCT00584584Phase 2
• Examination of the Role of Atrial Natriuretic Peptide Polymorphisms in Allergic Rhinitis and Asthma SeverityTerminatedNCT00584051
• Efficacy, Safety and PK of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo in the Symptomatic Treatment of SARCompletedNCT00574379Phase 2
• PK/PD and Steady State Efficacy Study of Bilastine Compared With Placebo Given Orally in the Treatment of the Symptoms of SAR in an EEC Model (5-arm)CompletedNCT00574210Phase 2
• Nasal Epithelium Gene Expression Profiling in Child Respiratory Allergic DiseaseCompletedNCT00569361Not applicable
• Safety and Efficacy Study of Epinastine Nasal Spray in Subjects With Seasonal Allergic Rhinitis (P08648)CompletedNCT00564421Phase 3
• A Randomized, Placebo Controlled Study to Determine the Efficacy and Speed of a Nasal Spray in Allergen Induced Seasonal Allergic RhinitisCompletedNCT00561717Phase 4
• Nasal Budesonide in Children With Rhinitis and/or Mild Obstructive Sleep Apnea SyndromeCompletedNCT00560586Phase 4
• Montelukast as a Controller of Atopic SyndromeCompletedNCT00559546Phase 4
• Evaluation and Long-Term Follow-Up of Patients With Allergic and Inflammatory DisordersTerminatedNCT00557895
• Efficacy of Levocetirizine and Cetirizine in Reducing Symptoms of Seasonal Allergic Rhinitis in Ragweed Sensitive SubjectsCompletedNCT00544388Phase 3
• Efficacy and Safety of Levocetirizine and Fexofenadine in Reducing Symptoms of Seasonal Allergic RhinitisCompletedNCT00542607Phase 4
• A Long-Term Examination of Asthma From Childhood Through AdolescenceCompletedNCT00541255
• An Evaluation of the Efficacy and Safety of TOLAMBA™ for Ragweed-Allergic Rhinitis in an Environmental Exposure ChamberCompletedNCT00537355Phase 2
• To Evaluate the Efficacy and Safety of Levocetirizine Versus Loratadine for Treatment of Seasonal Allergic RhinitisCompletedNCT00525278Phase 3
• Efficacy and Safety of Levocetirizine Versus Loratadine for the Treatment of Perennial Allergic RhinitisCompletedNCT00524836Phase 3
• Evaluation of Efficacy and Safety of Levocetirizine to Subjects With Perennial Allergic Rhinitis to House Dust MitesCompletedNCT00521131Phase 4
• Efficacy and Safety of Levocetirizine 8 Weeks Prior and After the Onset of the Grass Pollen Season in Subjects With SARCompletedNCT00521040Not applicable
• A Study To Investigate If MRI Scanning Is Effective At Seeing What Hayfever Drugs Do In Nasal Passage.CompletedNCT00517946
• Effects of Multiple Nasal Exposures to House Dust Mite Allergen on Nasal and Body Inflammation and Airway SensitivityCompletedNCT00513487Not applicable
• Efficacy Study for the Symptomatic Treatment of Seasonal Allergic RhinitisCompletedNCT00504933Phase 3

← Rhinitis overview